Conducting collaborative research locally, nationally and globally.
You are viewing an old version of this page. View the current version.
Compare with Current View Page History
« Previous Version 8 Next »
Costiniuk, C., MacCallum, C.A., Boivin, M., Rueda, S., Lacasse, G., Walsh, Z., Daeninck, P.J., Margolese, S., Mandarino, E., Deol, J.K., Sanchez, T. & Bell, A.D. 2023. Why a Distinct Medical Stream Is Necessary to Support Patients Using Cannabis for Medical Purposes. J Cannabis Res, 5(1):25.
Craig-Neil, A., Ho, J., Perri, M., Gaspar, M., Hunter, C., Rachlis, B., Kendall, C.E., Rueda, S., Burchell, A.N. & Pinto, A.D. 2023. Healthcare System Action on Employment as a Social Determinant of Health in People Living with Hiv: A Qualitative Study. PLoS One, 18(4):e0282421.
Imtiaz, S., Nigatu, Y.T., Ali, F., Douglas, L., Hamilton, H.A., Rehm, J., Rueda, S., Schwartz, R.M., Wells, S. & Elton-Marshall, T. 2023. Cannabis Legalization and Cannabis Use, Daily Cannabis Use and Cannabis-Related Problems among Adults in Ontario, Canada (2001–2019). Drug and Alcohol Dependence, 244:109765.
Nigatu, Y.T., Elton-Marshall, T., Rueda, S., Imtiaz, S. & Hamilton, H.A. 2023. Age, Period and Cohort Effects on Time Trends in Monthly Cannabis Use in Adult Population: 1996-2019. Drug Alcohol Rev, 42(5):1132-1141.
Tassone, F., Di Ciano, P., Liu, Y. & Rueda, S. 2023. On Offer to Ontario Consumers Three Years after Legalization: A Profile of Cannabis Products, Cannabinoid Content, Plant Type, and Prices. Front Psychiatry, 14:1111330.
Wardell, J.D., Rueda, S., Fox, N., Costiniuk, C.T., Jenabian, M.A., Margolese, S., Mandarino, E., Shuper, P., Hendershot, C.S., Cunningham, J.A., Arbess, G. & Singer, J. 2023. Disentangling Medicinal and Recreational Cannabis Use among People Living with HIV: An Ecological Momentary Assessment Study. AIDS Behav, 27(4):1350-1363.
Wiese, J.L., Watson, T.M., Owusu-Bempah, A., Hyshka, E., Wells, S., Robinson, M., Elton-Marshall, T. & Rueda, S. 2023. Overpoliced and Underrepresented: Perspectives on Cannabis Legalization from Members of Racialized Communities in Canada. Contemp Drug Probl, 50(1):25-45.